MITD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.083800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.724400E-02
Normal-vs-Stage2
1.007780E-01
Normal-vs-Stage3
1.700420E-01
Normal-vs-Stage4
4.124000E-01
Stage1-vs-Stage2
1.751580E-01
Stage1-vs-Stage3
9.667400E-01
Stage1-vs-Stage4
2.492200E-01
Stage2-vs-Stage3
2.927600E-01
Stage2-vs-Stage4
7.183200E-01
Stage3-vs-Stage4
3.972200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.282000E-02
Normal-vs-AfricanAmerican
7.870300E-02
Normal-vs-Asian
1.555430E-01
Caucasian-vs-AfricanAmerican
3.315800E-01
Caucasian-vs-Asian
7.285400E-01
AfricanAmerican-vs-Asian
5.838800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.729800E-02
Normal-vs-Female
9.098100E-02
Male-vs-Female
9.238400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.989150E-01
Normal-vs-Age(41-60Yrs)
9.316000E-02
Normal-vs-Age(61-80Yrs)
8.018500E-02
Normal-vs-Age(81-100Yrs)
3.441600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.999570E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.565600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.491600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.755200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.268800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.938300E-02
Normal-vs-Daily Drinker
1.912150E-01
Normal-vs-Weekly Drinker
1.379170E-01
Normal-vs-Occasional Drinker
1.563950E-02
Normal-vs-Social Drinker
2.057000E-01
Non Drinker-vs-Daily Drinker
4.782800E-01
Non Drinker-vs-Weekly Drinker
8.122600E-01
Non Drinker-vs-Occasional Drinker
9.597800E-01
Non Drinker-vs-Social Drinker
4.216600E-01
Daily Drinker-vs-Weekly Drinker
7.090200E-01
Daily Drinker-vs-Occasional Drinker
3.977000E-01
Daily Drinker-vs-Social Drinker
8.804000E-01
Weekly Drinker-vs-Occasional Drinker
7.590400E-01
Weekly Drinker-vs-Social Drinker
6.161000E-01
Occasional Drinker-vs-Social Drinker
3.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.777400E-01
Normal-vs-Grade 2
9.210200E-01
Normal-vs-Grade 3
9.047600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.86854999999486E-05
Grade 1-vs-Grade 3
5.042900E-04
Grade 1-vs-Grade 4
8.777400E-01
Grade 2-vs-Grade 3
7.012600E-01
Grade 2-vs-Grade 4
9.210200E-01
Grade 3-vs-Grade 4
9.047600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.839800E-02
Normal-vs-NonDiabetic
6.767800E-02
Diabetic-vs-NonDiabetic
7.685000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.754230E-01
Normal-vs-NoPancreatitis
6.629500E-02
Pancreatitis-vs-NoPancreatitis
6.790200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.404200E-02
Normal-vs-N1
1.056150E-01
N0-vs-N1
2.527400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.333000E-01
Normal-vs-TP53-NonMutant
4.067800E-02
TP53-Mutant-vs-TP53-NonMutant
1.30789999996939E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
